(4) Notwithstanding paragraph (e)(3) of this section, for a Part B rebatable drug that was billed under a NOC code during the calendar quarter beginning July 1, 2021, or the third full calendar quarter after such drug's first marketed date, whichever is later, the benchmark period CPI-U is the CPI-U for the first month of the third full calendar quarter after the Part B rebatable drug is assigned a billing and payment code other than a NOC code
I found this to be equally true of fledgling craftsman and the grand masters of the art
In a large county in the southeastern United States, Hughey and colleagues [24] developed a multicomponent built environment measure for youth using kernel density, and detailed audit of data on public parks, food stores, and restaurants
Nice photos
FDA is soliciting feedback about how necessary each one is, whether it should modify a specific proposed rule, etc